CINXE.COM

<!DOCTYPE html> <html lang="en-US" class="no-js"> <head>  <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="0192e7ff-6cd0-7eeb-a526-454b4ec9d90f" ></script> <script type="text/javascript"> function OptanonWrapper() { } </script>  <meta charset="UTF-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0"> <link rel="profile" href="http://gmpg.org/xfn/11">  <link rel="shortcut icon" href="https://tinygems.com/wp-content/themes/tinygems/favicon.ico" /> <meta property="og:image" content="https://tinygems.com/wp-content/themes/tinygems/fb-og-cnw.png" /> <link rel="stylesheet" href="https://tinygems.com/wp-content/themes/tinygems/css/angular-styles.css?1732401996" /> <link rel="stylesheet" href="https://tinygems.com/wp-content/themes/tinygems/js/fancyBox/source/jquery.fancybox.css" /> <link rel="apple-touch-icon-precomposed" href="https://tinygems.com/wp-content/themes/tinygems/ios-icon.png"/> <script src="https://ajax.googleapis.com/ajax/libs/angularjs/1.5.7/angular.min.js"></script> <script src="//ajax.googleapis.com/ajax/libs/angularjs/1.5.7/angular-animate.js"></script>  <link rel="stylesheet" href="https://use.typekit.net/xip4tqq.css"> <script>(function(html){html.className = html.className.replace(/\bno-js\b/,'js')})(document.documentElement);</script> <meta name='robots' content='index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1' />  <title>Lexaria Bioscience Corp. (NASDAQ: LEXX) To Hit High Ground in Q2 and Q3 2024 with Animal and Human GLP-1 Study Programs - TinyGems</title> <link rel="canonical" href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-to-hit-high-ground-in-q2-and-q3-2024-with-animal-and-human-glp-1-study-programs/" /> <meta property="og:locale" content="en_US" /> <meta property="og:type" content="article" /> <meta property="og:title" content="Lexaria Bioscience Corp. (NASDAQ: LEXX) To Hit High Ground in Q2 and Q3 2024 with Animal and Human GLP-1 Study Programs - TinyGems" /> <meta property="og:description" content="Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has announced its research plans for the evaluation of its patented DehydraTECH(TM) technology for the improved delivery of GLP-1 drugs designed to support prospective commercial partnering with global pharmaceutical companies.. This builds on the success achieved from a recent human pilot study, which yielded … Continue reading "Lexaria Bioscience Corp. (NASDAQ: LEXX) To Hit High Ground in Q2 and Q3 2024 with Animal and Human GLP-1 Study Programs"" /> <meta property="og:url" content="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-to-hit-high-ground-in-q2-and-q3-2024-with-animal-and-human-glp-1-study-programs/" /> <meta property="og:site_name" content="TinyGems" /> <meta property="article:publisher" content="https://www.facebook.com/tinygems.com" /> <meta property="article:published_time" content="2024-01-29T16:15:00+00:00" /> <meta property="article:modified_time" content="2024-01-29T17:24:39+00:00" /> <meta name="author" content="Christian Amiscua" /> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:creator" content="@tinygems" /> <meta name="twitter:site" content="@tinygems" /> <meta name="twitter:label1" content="Written by" /> <meta name="twitter:data1" content="Christian Amiscua" /> <meta name="twitter:label2" content="Est. reading time" /> <meta name="twitter:data2" content="4 minutes" /> <script type="application/ld+json" class="yoast-schema-graph">{"@context":"https://schema.org","@graph":[{"@type":"Article","@id":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-to-hit-high-ground-in-q2-and-q3-2024-with-animal-and-human-glp-1-study-programs/#article","isPartOf":{"@id":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-to-hit-high-ground-in-q2-and-q3-2024-with-animal-and-human-glp-1-study-programs/"},"author":{"name":"Christian Amiscua","@id":"https://tinygems.com/#/schema/person/d63601243e945851080e09e3984c0baa"},"headline":"Lexaria Bioscience Corp. (NASDAQ: LEXX) To Hit High Ground in Q2 and Q3 2024 with Animal and Human GLP-1 Study Programs","datePublished":"2024-01-29T16:15:00+00:00","dateModified":"2024-01-29T17:24:39+00:00","mainEntityOfPage":{"@id":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-to-hit-high-ground-in-q2-and-q3-2024-with-animal-and-human-glp-1-study-programs/"},"wordCount":819,"publisher":{"@id":"https://tinygems.com/#organization"},"articleSection":["Tiny Gem"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-to-hit-high-ground-in-q2-and-q3-2024-with-animal-and-human-glp-1-study-programs/","url":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-to-hit-high-ground-in-q2-and-q3-2024-with-animal-and-human-glp-1-study-programs/","name":"Lexaria Bioscience Corp. (NASDAQ: LEXX) To Hit High Ground in Q2 and Q3 2024 with Animal and Human GLP-1 Study Programs - TinyGems","isPartOf":{"@id":"https://tinygems.com/#website"},"datePublished":"2024-01-29T16:15:00+00:00","dateModified":"2024-01-29T17:24:39+00:00","breadcrumb":{"@id":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-to-hit-high-ground-in-q2-and-q3-2024-with-animal-and-human-glp-1-study-programs/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-to-hit-high-ground-in-q2-and-q3-2024-with-animal-and-human-glp-1-study-programs/"]}]},{"@type":"BreadcrumbList","@id":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-to-hit-high-ground-in-q2-and-q3-2024-with-animal-and-human-glp-1-study-programs/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://tinygems.com/"},{"@type":"ListItem","position":2,"name":"NewsRoom Articles","item":"https://tinygems.com/newsroom/newsroom-articles/"},{"@type":"ListItem","position":3,"name":"Lexaria Bioscience Corp. (NASDAQ: LEXX) To Hit High Ground in Q2 and Q3 2024 with Animal and Human GLP-1 Study Programs"}]},{"@type":"WebSite","@id":"https://tinygems.com/#website","url":"https://tinygems.com/","name":"TinyGems","description":"Spotlighting undiscovered companies with enormous upside potential.","publisher":{"@id":"https://tinygems.com/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://tinygems.com/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https://tinygems.com/#organization","name":"TinyGems","url":"https://tinygems.com/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https://tinygems.com/#/schema/logo/image/","url":"https://tinygems.com/wp-content/uploads/tg-amp-logo.png","contentUrl":"https://tinygems.com/wp-content/uploads/tg-amp-logo.png","width":190,"height":142,"caption":"TinyGems"},"image":{"@id":"https://tinygems.com/#/schema/logo/image/"},"sameAs":["https://www.facebook.com/tinygems.com","https://twitter.com/tinygems"]},{"@type":"Person","@id":"https://tinygems.com/#/schema/person/d63601243e945851080e09e3984c0baa","name":"Christian Amiscua","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https://tinygems.com/#/schema/person/image/","url":"https://secure.gravatar.com/avatar/8a84f51d57cade327d2817ae67a6d290?s=96&d=mm&r=g","contentUrl":"https://secure.gravatar.com/avatar/8a84f51d57cade327d2817ae67a6d290?s=96&d=mm&r=g","caption":"Christian Amiscua"},"url":"https://tinygems.com/author/tg_ibn_christian/"}]}</script>  <link rel="amphtml" href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-to-hit-high-ground-in-q2-and-q3-2024-with-animal-and-human-glp-1-study-programs/amp/" /><meta name="generator" content="AMP for WP 1.0.98"/><link rel='dns-prefetch' href='//ajax.googleapis.com' /> <link rel='dns-prefetch' href='//cdnjs.cloudflare.com' /> <link rel='stylesheet' id='wp-block-library-css' href='https://tinygems.com/wp-includes/css/dist/block-library/style.min.css' type='text/css' media='all' /> <style id='classic-theme-styles-inline-css' type='text/css'> /*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none} </style> <style id='global-styles-inline-css' type='text/css'> body{--wp--preset--color--black: #000000;--wp--preset--color--cyan-bluish-gray: #abb8c3;--wp--preset--color--white: #ffffff;--wp--preset--color--pale-pink: #f78da7;--wp--preset--color--vivid-red: #cf2e2e;--wp--preset--color--luminous-vivid-orange: #ff6900;--wp--preset--color--luminous-vivid-amber: #fcb900;--wp--preset--color--light-green-cyan: #7bdcb5;--wp--preset--color--vivid-green-cyan: #00d084;--wp--preset--color--pale-cyan-blue: #8ed1fc;--wp--preset--color--vivid-cyan-blue: #0693e3;--wp--preset--color--vivid-purple: #9b51e0;--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple: linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan: linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange: linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red: linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray: linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum: linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple: linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux: linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk: linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean: linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass: linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight: linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--font-size--small: 13px;--wp--preset--font-size--medium: 20px;--wp--preset--font-size--large: 36px;--wp--preset--font-size--x-large: 42px;--wp--preset--spacing--20: 0.44rem;--wp--preset--spacing--30: 0.67rem;--wp--preset--spacing--40: 1rem;--wp--preset--spacing--50: 1.5rem;--wp--preset--spacing--60: 2.25rem;--wp--preset--spacing--70: 3.38rem;--wp--preset--spacing--80: 5.06rem;--wp--preset--shadow--natural: 6px 6px 9px rgba(0, 0, 0, 0.2);--wp--preset--shadow--deep: 12px 12px 50px rgba(0, 0, 0, 0.4);--wp--preset--shadow--sharp: 6px 6px 0px rgba(0, 0, 0, 0.2);--wp--preset--shadow--outlined: 6px 6px 0px -3px rgba(255, 255, 255, 1), 6px 6px rgba(0, 0, 0, 1);--wp--preset--shadow--crisp: 6px 6px 0px rgba(0, 0, 0, 1);}:where(.is-layout-flex){gap: 0.5em;}:where(.is-layout-grid){gap: 0.5em;}body .is-layout-flow > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}body .is-layout-flow > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}body .is-layout-flow > .aligncenter{margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}body .is-layout-constrained > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}body .is-layout-constrained > .aligncenter{margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > :where(:not(.alignleft):not(.alignright):not(.alignfull)){max-width: var(--wp--style--global--content-size);margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > .alignwide{max-width: var(--wp--style--global--wide-size);}body .is-layout-flex{display: flex;}body .is-layout-flex{flex-wrap: wrap;align-items: center;}body .is-layout-flex > *{margin: 0;}body .is-layout-grid{display: grid;}body .is-layout-grid > *{margin: 0;}:where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;}:where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;}.has-black-color{color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-color{color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-color{color: var(--wp--preset--color--white) !important;}.has-pale-pink-color{color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-color{color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-color{color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-color{color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-color{color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-color{color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-color{color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-color{color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-color{color: var(--wp--preset--color--vivid-purple) !important;}.has-black-background-color{background-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-background-color{background-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-background-color{background-color: var(--wp--preset--color--white) !important;}.has-pale-pink-background-color{background-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-background-color{background-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-background-color{background-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-background-color{background-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-background-color{background-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-background-color{background-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-background-color{background-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-background-color{background-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-background-color{background-color: var(--wp--preset--color--vivid-purple) !important;}.has-black-border-color{border-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-border-color{border-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-border-color{border-color: var(--wp--preset--color--white) !important;}.has-pale-pink-border-color{border-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-border-color{border-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-border-color{border-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-border-color{border-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-border-color{border-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-border-color{border-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-border-color{border-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-border-color{border-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-border-color{border-color: var(--wp--preset--color--vivid-purple) !important;}.has-vivid-cyan-blue-to-vivid-purple-gradient-background{background: var(--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple) !important;}.has-light-green-cyan-to-vivid-green-cyan-gradient-background{background: var(--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan) !important;}.has-luminous-vivid-amber-to-luminous-vivid-orange-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange) !important;}.has-luminous-vivid-orange-to-vivid-red-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-orange-to-vivid-red) !important;}.has-very-light-gray-to-cyan-bluish-gray-gradient-background{background: var(--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray) !important;}.has-cool-to-warm-spectrum-gradient-background{background: var(--wp--preset--gradient--cool-to-warm-spectrum) !important;}.has-blush-light-purple-gradient-background{background: var(--wp--preset--gradient--blush-light-purple) !important;}.has-blush-bordeaux-gradient-background{background: var(--wp--preset--gradient--blush-bordeaux) !important;}.has-luminous-dusk-gradient-background{background: var(--wp--preset--gradient--luminous-dusk) !important;}.has-pale-ocean-gradient-background{background: var(--wp--preset--gradient--pale-ocean) !important;}.has-electric-grass-gradient-background{background: var(--wp--preset--gradient--electric-grass) !important;}.has-midnight-gradient-background{background: var(--wp--preset--gradient--midnight) !important;}.has-small-font-size{font-size: var(--wp--preset--font-size--small) !important;}.has-medium-font-size{font-size: var(--wp--preset--font-size--medium) !important;}.has-large-font-size{font-size: var(--wp--preset--font-size--large) !important;}.has-x-large-font-size{font-size: var(--wp--preset--font-size--x-large) !important;} .wp-block-navigation a:where(:not(.wp-element-button)){color: inherit;} :where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;} :where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;} .wp-block-pullquote{font-size: 1.5em;line-height: 1.6;} </style> <link rel='stylesheet' id='contact-form-7-css' href='https://tinygems.com/wp-content/plugins/contact-form-7/includes/css/styles.css' type='text/css' media='all' /> <link rel='stylesheet' id='genericons-css' href='https://tinygems.com/wp-content/themes/tinygems/genericons/genericons.css' type='text/css' media='all' /> <link rel='stylesheet' id='font-awesome-css' href='https://tinygems.com/wp-content/themes/tinygems/css/fontawesome-all.min.css' type='text/css' media='all' /> <link rel='stylesheet' id='tinygems-style-css' href='https://tinygems.com/wp-content/themes/tinygems/style.css' type='text/css' media='all' /> <link rel='stylesheet' id='customstyles-css' href='https://tinygems.com/wp-content/themes/tinygems/css/styles.css?1732401996' type='text/css' media='all' /> <link rel='stylesheet' id='tablepress-default-css' href='https://tinygems.com/wp-content/plugins/tablepress/css/build/default.css' type='text/css' media='all' /> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/jquery/jquery.min.js" id="jquery-core-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/jquery/jquery-migrate.min.js" id="jquery-migrate-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/fancyBox/source/jquery.fancybox.js" id="fancy-js"></script> <script type="text/javascript" src="//ajax.googleapis.com/ajax/libs/angularjs/1.5.7/angular-resource.js" id="ngresource-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/ng-lodash-master/build/ng-lodash.min.js" id="nglodash-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/moment.min.js" id="moment_min-js"></script> <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/angular-moment/1.0.0-beta.6/angular-moment.min.js" id="ngmoment-js"></script>  <link rel="https://api.w.org/" href="https://tinygems.com/wp-json/" /><link rel="alternate" type="application/json" href="https://tinygems.com/wp-json/wp/v2/posts/39305" /><link rel='shortlink' href='https://tinygems.com/?p=39305' /> <link rel="alternate" type="application/json+oembed" href="https://tinygems.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Ftinygems.com%2Flexaria-bioscience-corp-nasdaq-lexx-to-hit-high-ground-in-q2-and-q3-2024-with-animal-and-human-glp-1-study-programs%2F" /> <link rel="alternate" type="text/xml+oembed" href="https://tinygems.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Ftinygems.com%2Flexaria-bioscience-corp-nasdaq-lexx-to-hit-high-ground-in-q2-and-q3-2024-with-animal-and-human-glp-1-study-programs%2F&format=xml" />  <script async src="https://www.googletagmanager.com/gtag/js?id=G-X56RVJCEJS"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-X56RVJCEJS'); </script>  <script async src="https://tag.pearldiver.io/ldc.js?pid=7315ce62cb84c70d74b0564eb49eda9b&aid=16de03f2"></script> </head> <body class="post-template-default single single-post postid-39305 single-format-standard group-blog">   <div class="banner"> <div class="container"> <div class="logo"><a href="https://tinygems.com/"><img src="https://tinygems.com/wp-content/themes/tinygems/images/tinygems.png" alt="tinygems Logo"/></a></div> <div class="banner-right"> <h3>Spotlighting undiscovered companies with enormous upside potential.</h3> <div class="banner-right-flex"> <h4>Contact us: <span>(310) 299-1717</span></h4> <div class="social"> <ul> <li class="twitter"><a href="https://twitter.com/tinygems" target="_blank" rel="nofollow"></a></li> <li class="linkedin"><a href="https://www.linkedin.com/company/5133985?trk=tyah&trkInfo=tarId%3A1402372889813%2Ctas%3Atinygem%2Cidx%3A1-1-1" target="_blank" rel="nofollow"></a></li> <li class="facebook"><a href="https://www.facebook.com/tinygems.net" target="_blank" rel="nofollow"></a></li> </ul> </div></div> </div>  <div id="hamburger"><span>Spotlighting undiscovered companies with enormous upside potential.</span></div> <div id="Menu"> <div class="menu-main-navigation-container"><ul id="menu-main-navigation" class="menu"><li id="menu-item-31636" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-31636"><a href="https://tinygems.com/">Home</a></li> <li id="menu-item-51" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-51"><a href="https://tinygems.com/about/">About</a></li> <li id="menu-item-5539" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-5539"><a href="https://tinygems.com/tiny-gems/">Tiny Gems</a></li> <li id="menu-item-17" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-17"><a href="https://tinygems.com/newsroom/">NewsRoom</a></li> <li id="menu-item-34478" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34478"><a href="https://tinygems.com/newsletter-archives/">Newsletter Archives</a></li> <li id="menu-item-34872" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-34872"><a target="_blank" rel="noopener" href="https://www.investorbrandnetwork.com/events/">Events</a></li> <li id="menu-item-49" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-49"><a href="https://tinygems.com/contact/">Contact</a></li> </ul></div> </div> </div> </div>  <div class="article-headlines"> <div class="container"> <div class="headlines-label"><a href="/newsroom/newsroom-articles/">Headlines</a></div> <div id="Headline"> <div class="cycle-slideshow" data-cycle-fx="scrollVert" data-cycle-timeout="5000" data-cycle-slides="> div">  <div> <a href="/gemxx-corp-gemz-announces-definitive-agreement-with-latin-energy-partners-in-strategic-latin-america-venture/">GEMXX Corp. (GEMZ) Announces Definitive Agreement with Latin Energy Partners in Strategic Latin America Venture</a> </div><div> <a href="/mullen-automotive-inc-nasdaq-muln-subsidiary-announces-first-dealership-deal-in-market-projected-to-see-record-sales/">Mullen Automotive Inc. (MULN) Subsidiary Announces First Dealership Deal in Market Projected to See Record Sales</a> </div><div> <a href="/lexaria-bioscience-corp-nasdaq-lexx-hires-new-ceo-amid-shift-in-focus-to-pharmaceutical-industry-collaboration-and-operations/">Lexaria Bioscience Corp. (LEXX) Hires New CEO in Focus to Pharmaceutical Industry Collaboration and Operations</a> </div><div> <a href="/inmed-pharmaceuticals-inc-s-nasdaq-inm-inm-901-a-promising-new-candidate-for-alzheimers-therapy/">InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy</a> </div><div> <a href="/clene-inc-nasdaq-clnn-presents-promising-preliminary-data-on-cnm-au8r-for-rett-syndrome-treatment/">Clene Inc. (CLNN) Presents Promising Preliminary Data on CNM-Au8(R) for Rett Syndrome Treatment</a> </div>   <p></p>   <p></p>  </div> </div> </div> </div> <div class="breadcrumb"><div class="container"><span><span><a href="https://tinygems.com/">Home</a></span> / <span><a href="https://tinygems.com/newsroom/newsroom-articles/">NewsRoom Articles</a></span> / <span class="breadcrumb_last" aria-current="page">Lexaria Bioscience Corp. (NASDAQ: LEXX) To Hit High Ground in Q2 and Q3 2024 with Animal and Human GLP-1 Study Programs</span></span></div></div>  <div class="content"> <div class="container"> <article id="post-39305" class="post-39305 post type-post status-publish format-standard hentry category-tinygem"> <header class="entry-header"> <h1 class="entry-title">Lexaria Bioscience Corp. (NASDAQ: LEXX) To Hit High Ground in Q2 and Q3 2024 with Animal and Human GLP-1 Study Programs</h1> <p class="article-date">January 29, 2024</p> </header> <div class="ad-leader"></div> <div class="single-article-left"> <div class="entry-content"> <ul> <li>Lexaria, a global innovator in drug delivery platforms, has announced its GLP-1 research plans for the 2024 calendar year</li> <li>The company will kick off its chronic dosing animal study in March/April, followed by the human pilot study #2, kicking off at around the same time</li> <li>The third human pilot study will start in May/June followed by a chronic dosing human study that will involve 70-90 pre-diabetic and type-2 diabetic human patients</li> <li>These studies will evaluate DehydraTECH for the improved delivery of GLP-1 drugs, designed to support prospective commercial partnering with global pharmaceutical companies</li> </ul> <p><a href="https://www.investorbrandnetwork.com/clients/lexaria-bioscience-corp/" target="_blank" rel="noreferrer noopener">Lexaria Bioscience (NASDAQ: LEXX)</a>, a global innovator in drug delivery platforms, has announced its research plans for the evaluation of its patented DehydraTECH(TM) technology for the improved delivery of GLP-1 drugs designed to support prospective commercial partnering with global pharmaceutical companies.. This builds on the success achieved from a recent human pilot study, which yielded impressive results, demonstrating superior pharmacokinetic (“PK”) oral delivery performance of the DehydraTECH-enhanced GLP-1 drug, semaglutide, which is currently available commercially as Rybelsus(R) (<a href="https://ibn.fm/uOdpf" target="_blank" rel="noreferrer noopener">https://ibn.fm/uOdpf</a>).</p> <p>Kicking off at the end of Q1 or the beginning of Q2 is Lexaria’s chronic dosing animal study – an obese rat diabetic-conditioned study that will run for 12 weeks. The study will involve approximately 12 study arms and 6-10 animals per arm. It will also explore varied DehydraTECH formulations of semaglutide and liraglutide, alone and together with DehydraTECH-CBD, to evaluate overall efficiency.</p> <p>Lexaria will also kick off human pilot study #2 in March/April. This study will involve up to 8 healthy volunteers and seek to explore the effectiveness of a single dose of oral ingested DehydraTECH-semaglutide capsules. It will seek to determine whether GLP-1 drug absorption via this route is effective and well tolerated as an alternative to the conventional oral ingestible route. It will evaluate blood sugar control, tolerability, and PK, with the DehydraTECH compositions compound-formulated using commercially available Rybelsus tablets as the semaglutide input material.</p> <p>The third human pilot study will be in May/June, studying a single dose of orally ingested DehydraTECH-tirzepatide capsules to evaluate tolerability, PK, and blood sugar. The capsules will be compound-formulated using Zepbound(R). This product is currently administered by injection only but will be used as an input material to produce the capsules used for the study. This will set Lexaria up for its chronic dosing human study, which will involve 70-90 pre-diabetic and type-2 diabetic human patients, dosing daily using oral DehydraTECH capsules for 12 weeks. The study will also evaluate tolerability, PK, weight loss, blood sugar levels, and more.</p> <p>The chronic dosing human study’s primary goal will be to compare DehydraTECH-processed semaglutide capsules to DehydraTECH-CBD capsules alone and together in combination, relative to a placebo control over an extended period. Insights from this study will also inform the company’s long-term stability testing, which will seek to explore the chemical and microbiological purity and stability of select DehydraTECH compositions that it prepares for this and future animal and human studies.</p> <p>These studies highlight what is set to be a significant year for Lexaria. The ambitious goals show confidence in its DehydraTECH technology and its viability in the market.</p> <p>For more information, visit the company’s website at <a href="http://www.lexariabioscience.com/" target="_blank" rel="noreferrer noopener">www.LexariaBioscience.com</a>.</p> <p><strong>NOTE TO INVESTORS:</strong> The latest news and updates relating to LEXX are available in the company’s newsroom at <a href="https://ibn.fm/LEXX" target="_blank" rel="noreferrer noopener">https://ibn.fm/LEXX</a></p> <p><strong>About TinyGems</strong></p> <p><a href="https://tinygems.com/" target="_blank" rel="noreferrer noopener">TinyGems</a> is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the <a href="https://www.investorbrandnetwork.com/dynamic-brand-portfolio/" target="_blank" rel="noreferrer noopener"><strong>Dynamic Brand Portfolio</strong></a> @ <a href="https://www.investorbrandnetwork.com/" target="_blank" rel="noreferrer noopener"><strong>IBN</strong></a> that delivers<strong>:</strong> (1) access to a vast network of wire solutions via <a href="https://www.investorwire.com/" target="_blank" rel="noreferrer noopener">InvestorWire</a> to efficiently and effectively reach a myriad of target markets, demographics and diverse industries<strong>;</strong> (2) article and <a href="https://www.investorbrandnetwork.com/solutions/press-distribution-via-investorwire/syndication-partners/" target="_blank" rel="noreferrer noopener">editorial syndication to 5,000+ outlets</a><strong>;</strong> (3) enhanced <a href="https://www.investorwire.com/investorwire-press-distribution/press-release-enhancement/" target="_blank" rel="noreferrer noopener">press release enhancement</a> to ensure maximum impact<strong>;</strong> (4) <a href="https://www.investorbrandnetwork.com/social-media-network/" target="_blank" rel="noreferrer noopener">social media distribution</a> via IBN to millions of social media followers<strong>;</strong> and (5) a full array of tailored <a href="https://www.investorbrandnetwork.com/solutions/" target="_blank" rel="noreferrer noopener">corporate communications solutions</a>. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.</p> <p><strong>To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)</strong></p> <p>For more information, please visit <a href="https://tinygems.com/" target="_blank" rel="noreferrer noopener">https://www.TinyGems.com</a></p> <p>Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: <a href="https://tinygems.com/Disclaimer" target="_blank" rel="noreferrer noopener">https://www.TinyGems.com/Disclaimer</a></p> <p>TinyGems<br>Los Angeles, CA<br><a href="https://tinygems.com/" target="_blank" rel="noreferrer noopener">www.TinyGems.com</a><br>310.299.1717 Office<br><a href="mailto:Editor@TinyGems.com" target="_blank" rel="noreferrer noopener">Editor@TinyGems.com</a></p> <p>TinyGems is powered by <a href="https://www.investorbrandnetwork.com/" target="_blank" rel="noreferrer noopener">IBN</a></p> </div> <nav class="navigation post-navigation" aria-label="Posts"> <h2 class="screen-reader-text">Post navigation</h2> <div class="nav-links"><div class="nav-previous"><a href="https://tinygems.com/diamond-lake-minerals-inc-dlmi-builds-digital-token-bridge-to-traditional-stocks-bonds-market/" rel="prev"><span class="meta-nav" aria-hidden="true">Previous</span> <span class="screen-reader-text">Previous post:</span> <span class="post-title">Diamond Lake Minerals Inc. (DLMI) Builds Digital Token Bridge to Traditional Stocks, Bonds Market</span></a></div><div class="nav-next"><a href="https://tinygems.com/gemxx-corp-gemz-sequire-presentation-demonstrates-major-competitive-advantage-with-control-of-the-mining-value-chain/" rel="next"><span class="meta-nav" aria-hidden="true">Next</span> <span class="screen-reader-text">Next post:</span> <span class="post-title">GEMXX Corp. (GEMZ) Sequire Presentation Demonstrates Major Competitive Advantage with Control of the Mining Value Chain</span></a></div></div> </nav> </div> <div class="single-article-right"> <div class="ad-sidebar"></div> <aside id="secondary" class="sidebar widget-area" role="complementary"> <section id="recent-posts-2" class="widget widget_recent_entries"> <h2 class="widget-title">Recent Articles</h2> <ul> <li> <a href="https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/">Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-hires-new-ceo-amid-shift-in-focus-to-pharmaceutical-industry-collaboration-and-operations/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires New CEO Amid Shift in Focus to Pharmaceutical Industry Collaboration and Operations</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-demonstrates-continued-dehydratechtm-liraglutide-performance-with-ongoing-glp-1-diabetes-animal-study/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Demonstrates Continued DehydraTECH(TM)-Liraglutide Performance with Ongoing GLP-1 Diabetes Animal Study</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-yields-extremely-interesting-results-for-dehydratechtm-liraglutide-in-ongoing-diabetes-animal-study/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Yields “Extremely Interesting” Results for DehydraTECH(TM) Liraglutide in Ongoing Diabetes Animal Study</a> </li> <li> <a href="https://tinygems.com/inmed-pharmaceuticals-inc-s-nasdaq-inm-inm-901-a-promising-new-candidate-for-alzheimers-therapy/">InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-validates-technologys-superiority-moving-closer-to-a-share-in-the-global-diabetes-treatment-market/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Validates Technology’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market</a> </li> <li> <a href="https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/">InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drug INM-901</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-targeting-oral-glp-1-alternatives-for-diabetes-and-obesity-treatment/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Oral GLP-1 Alternatives for Diabetes and Obesity Treatment</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-exploring-alternative-diabetes-and-obesity-treatments/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Alternative Diabetes and Obesity Treatments</a> </li> </ul> </section> </aside> <h2>Archives</h2> <div class="selectamonth">Select A Month</div> <div class="sam-outer-container"> <div class="sam-inner-container"> <div class="sam-panel"> <li><a href='https://tinygems.com/2024/11/'>November 2024</a></li> <li><a href='https://tinygems.com/2024/09/'>September 2024</a></li> <li><a href='https://tinygems.com/2024/08/'>August 2024</a></li> <li><a href='https://tinygems.com/2024/07/'>July 2024</a></li> <li><a href='https://tinygems.com/2024/06/'>June 2024</a></li> <li><a href='https://tinygems.com/2024/05/'>May 2024</a></li> <li><a href='https://tinygems.com/2024/04/'>April 2024</a></li> <li><a href='https://tinygems.com/2024/03/'>March 2024</a></li> <li><a href='https://tinygems.com/2024/02/'>February 2024</a></li> <li><a href='https://tinygems.com/2024/01/'>January 2024</a></li> <li><a href='https://tinygems.com/2023/12/'>December 2023</a></li> <li><a href='https://tinygems.com/2023/11/'>November 2023</a></li> <li><a href='https://tinygems.com/2023/10/'>October 2023</a></li> <li><a href='https://tinygems.com/2023/09/'>September 2023</a></li> <li><a href='https://tinygems.com/2023/08/'>August 2023</a></li> <li><a href='https://tinygems.com/2023/07/'>July 2023</a></li> <li><a href='https://tinygems.com/2023/06/'>June 2023</a></li> <li><a href='https://tinygems.com/2023/05/'>May 2023</a></li> <li><a href='https://tinygems.com/2023/04/'>April 2023</a></li> <li><a href='https://tinygems.com/2023/03/'>March 2023</a></li> <li><a href='https://tinygems.com/2023/02/'>February 2023</a></li> <li><a href='https://tinygems.com/2023/01/'>January 2023</a></li> <li><a href='https://tinygems.com/2022/12/'>December 2022</a></li> <li><a href='https://tinygems.com/2022/11/'>November 2022</a></li> <li><a href='https://tinygems.com/2022/10/'>October 2022</a></li> <li><a href='https://tinygems.com/2022/09/'>September 2022</a></li> <li><a href='https://tinygems.com/2022/08/'>August 2022</a></li> <li><a href='https://tinygems.com/2022/07/'>July 2022</a></li> <li><a href='https://tinygems.com/2022/06/'>June 2022</a></li> <li><a href='https://tinygems.com/2022/05/'>May 2022</a></li> </div> </div> </div> </div> </article> </div> </div>   <div class="red-panel"> <div class="container"> <p>Contact us: <span>(310) 299-1717</span></p> </div> </div>  <div class="footer"> <div class="container"> <div class="quarter"> <a href="https://tinygems.com/"><img src="https://tinygems.com/wp-content/themes/tinygems/images/tinygems-white.png" alt="TinyGems" title="TinyGems"/></a> <h6><a href="https://tinygems.com/">TinyGems</a></h6> <p>8033 Sunset Blvd. Suite TG-1037 <br/>Los Angeles, CA 90046 <br/>(310) 299-1717</p> <ul class="social"> <li class="twitter"><a href="https://twitter.com/tinygems" target="_blank" rel="nofollow"></a></li> <li class="linkedin"><a href="https://www.linkedin.com/company/5133985?trk=tyah&trkInfo=tarId%3A1402372889813%2Ctas%3Atinygem%2Cidx%3A1-1-1" target="_blank" rel="nofollow"></a></li> <li class="facebook"><a href="https://www.facebook.com/tinygems.net" target="_blank" rel="nofollow"></a></li> </ul> </div> <div class="quarter"> <div class="menu-footer-solutions-container"><ul id="menu-footer-solutions" class="menu"><li id="menu-item-31334" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-31334"><a href="https://tinygems.com/tiny-gems/">Tiny Gems</a></li> <li id="menu-item-33891" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-33891"><a href="https://tinygems.com/newsroom/">NewsRoom</a></li> <li id="menu-item-34479" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34479"><a href="https://tinygems.com/newsletter-archives/">Newsletter Archives</a></li> <li id="menu-item-34873" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-34873"><a target="_blank" rel="noopener" href="https://www.investorbrandnetwork.com/events/">Events</a></li> </ul></div> </div> <div class="quarter"> <div class="menu-footer-other-container"><ul id="menu-footer-other" class="menu"><li id="menu-item-34480" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34480"><a href="https://tinygems.com/about/">About</a></li> <li id="menu-item-34481" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-privacy-policy menu-item-34481"><a rel="privacy-policy" href="https://tinygems.com/disclaimer/">Disclaimer</a></li> <li id="menu-item-34482" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34482"><a href="https://tinygems.com/contact/">Contact</a></li> </ul></div> </div> <div class="quarter"> <div class="quickquote"> <h6>Quote / Research</h6> <input type="text" id="SymbolField" placeholder="Enter Symbol"> <a href="" class="getQuote">Get Quote</a> <h6 class="sitesearch">Site Search</h6> <form role="search" method="get" class="search-form" action="https://tinygems.com/"> <input type="search" class="search-field" placeholder="Search Term …" value="" name="s" /> <button type="submit" class="search-submit">Search</button> </form> </div> </div> <div class="copyright"> <p>Copyright © <script language="JavaScript" type="text/javascript"> var d=new Date(); yr=d.getFullYear(); if (yr!=2020) document.write("2020 - "+yr); else {document.write(""+yr);} </script>. TinyGems / 8033 Sunset Blvd. Suite TG-1037, Los Angeles, CA 90046 (310) 299-1717 / <a href="/disclaimer">Disclaimers</a></p> <p class="captcha-statement">Forms are protected by reCAPTCHA and the Google <a href="https://policies.google.com/privacy" target="_blank" rel="noopener noreferrer">Privacy Policy</a> and <a href="https://policies.google.com/terms" target="_blank" rel="noopener noreferrer">Terms of Service</a> apply.</p> </div> </div> </div>  <script id="tawk-script" type="text/javascript"> var Tawk_API = Tawk_API || {}; var Tawk_LoadStart=new Date(); (function(){ var s1 = document.createElement( 'script' ),s0=document.getElementsByTagName( 'script' )[0]; s1.async = true; s1.src = 'https://embed.tawk.to/6310b06854f06e12d8922d61/1gbsj268n'; s1.charset = 'UTF-8'; s1.setAttribute( 'crossorigin','*' ); s0.parentNode.insertBefore( s1, s0 ); })(); </script>  <script type="text/javascript" id="ges_angular_script-js-extra"> /* <![CDATA[ */ var wp_data = {"ajaxurl":"https:\/\/tinygems.com\/wp-admin\/admin-ajax.php","symbol":null}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/ang-script.js?1732401996" id="ges_angular_script-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/plugins/contact-form-7/includes/swv/js/index.js" id="swv-js"></script> <script type="text/javascript" id="contact-form-7-js-extra"> /* <![CDATA[ */ var wpcf7 = {"api":{"root":"https:\/\/tinygems.com\/wp-json\/","namespace":"contact-form-7\/v1"}}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/plugins/contact-form-7/includes/js/index.js" id="contact-form-7-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/skip-link-focus-fix.js" id="tinygems-skip-link-focus-fix-js"></script> <script type="text/javascript" id="tinygems-script-js-extra"> /* <![CDATA[ */ var screenReaderText = {"expand":"expand child menu","collapse":"collapse child menu"}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/functions.js" id="tinygems-script-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/js.cookie.min.js" id="tinygems-cookies-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/custom.js" id="tinygems-myscripts-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/jquery.cycle2.min.js" id="tinygems-cycle-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/jquery.cycle2.scrollVert.min.js" id="tinygems-cycle-vert-js"></script> <script type="text/javascript" src="https://www.google.com/recaptcha/api.js?render=6LdoYukfAAAAANjIa2I8Gxc0Ty_xdMITmbwMhOmA" id="google-recaptcha-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/dist/vendor/wp-polyfill-inert.min.js" id="wp-polyfill-inert-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/dist/vendor/regenerator-runtime.min.js" id="regenerator-runtime-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/dist/vendor/wp-polyfill.min.js" id="wp-polyfill-js"></script> <script type="text/javascript" id="wpcf7-recaptcha-js-extra"> /* <![CDATA[ */ var wpcf7_recaptcha = {"sitekey":"6LdoYukfAAAAANjIa2I8Gxc0Ty_xdMITmbwMhOmA","actions":{"homepage":"homepage","contactform":"contactform"}}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/plugins/contact-form-7/modules/recaptcha/index.js" id="wpcf7-recaptcha-js"></script> </body> </html>